Identification | Back Directory | [Name]
Methyl alpha-bromo-2-chlorophenylacetate | [CAS]
85259-19-4 | [Synonyms]
-Bromo-2-chlorophenylacetate Methyl a-Bromo-2-chlorobenzeneacetat Methyl a-Bromo-2-chlorophenylacetate Methyl α-Bromo-2-chlorobenzeneacetate Methyl a-Bromo-2-chlorobenzeneacetate Methyl alpha-bromo-2-chlorophenylacetate a-Bromo-2-chlorobenzeneacetic Acid Methyl Ester α-Bromo-2-chloro benzeneacetic Acid Methyl Ester 2-Bromo-2-(2-chlorophenyl)acetic acid methyl ester alpha-Bromo-2-chloro-phenylacetic acid methyl ester | [EINECS(EC#)]
617-693-6 | [Molecular Formula]
C9H8BrClO2 | [MDL Number]
MFCD08444353 | [MOL File]
85259-19-4.mol | [Molecular Weight]
263.52 |
Chemical Properties | Back Directory | [Appearance]
Light-Yellow Oil | [Boiling point ]
281 °C | [density ]
1.567 | [refractive index ]
1.5630 to 1.5670 | [Fp ]
124 °C | [storage temp. ]
Refrigerator | [solubility ]
Dichloromethane, Ether, Ethyl Acetate, Methanol | [form ]
Solid | [color ]
Light Beige |
Hazard Information | Back Directory | [Chemical Properties]
Light-Yellow Oil | [Uses]
Methyl α-Bromo-2-chlorophenylacetate (cas# 85259-19-4) is a compound useful in organic synthesis. | [Synthesis]
General procedure for the synthesis of α-bromo-2-chlorophenylacetic acid methyl ester from o-chlorophenylacetic acid methyl ester: N-bromosuccinimide (1.04 g, 5.84 mmol) and azobisisobutyronitrile (43 mg) were sequentially added to a stirred solution of methyl 2-chlorophenylacetate (0.86 mL, 5.31 mmol) in dichloromethane (10.2 mL, 159 mmol). The reaction mixture was stirred at 100 °C for 16 h under argon protection. After completion of the reaction, the mixture was cooled to room temperature, diluted with ether and filtered. The filtrate was concentrated under reduced pressure to remove the solvent to give an oily residue containing succinimide (456 mg), which was diluted with heptane and filtered again. Finally, the solvent was removed by distillation under reduced pressure to afford methyl α-bromo-2-chlorophenylacetate (1.38 g, 4.56 mmol) in 86% yield. The product was characterized by 1H NMR (500 MHz, CDCl3): δ 7.69 (dd, J = 7.6, 1.8 Hz, 1H), 7.31 (dd, J = 7.6, 1.7 Hz, 1H), 7.24 (td, J = 7.6, 1.7 Hz, 1H), 7.21 (dd, J = 7.5, 1.8 Hz, 1H), 5.84 (s 1H), 3.74 (s, 3H). | [References]
[1] Patent: WO2018/149856, 2018, A1. Location in patent: Paragraph 93-94 [2] Patent: WO2018/149853, 2018, A1. Location in patent: Page/Page column 96 [3] Angewandte Chemie - International Edition, 2013, vol. 52, # 16, p. 4440 - 4444 [4] Angew. Chem., 2013, vol. 125, # 16, p. 4536 - 4540,5 [5] Journal of Medicinal Chemistry, 1993, vol. 36, # 23, p. 3738 - 3742 |
|
|